opd laboratories limited
opd laboratories limited Company Information
Company Number
03181478
Website
-Registered Address
fifth floor watson house, 54-60 baker street, london, W1U 7BU
Industry
Wholesale of pharmaceutical goods
Telephone
01923444999
Next Accounts Due
May 2024
Group Structure
View All
Shareholders
orion holdings (uk) ltd 100%
opd laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of OPD LABORATORIES LIMITED at £16.9m based on a Turnover of £19.8m and 0.85x industry multiple (adjusted for size and gross margin).
opd laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of OPD LABORATORIES LIMITED at £2.9m based on an EBITDA of £427.4k and a 6.71x industry multiple (adjusted for size and gross margin).
opd laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of OPD LABORATORIES LIMITED at £0 based on Net Assets of £-3m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Opd Laboratories Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Opd Laboratories Limited Overview
Opd Laboratories Limited is a live company located in london, W1U 7BU with a Companies House number of 03181478. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 1996, it's largest shareholder is orion holdings (uk) ltd with a 100% stake. Opd Laboratories Limited is a mature, mid sized company, Pomanda has estimated its turnover at £19.8m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Opd Laboratories Limited Health Check
Pomanda's financial health check has awarded Opd Laboratories Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £19.8m, make it smaller than the average company (£26.2m)
- Opd Laboratories Limited
£26.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (4%)
- Opd Laboratories Limited
4% - Industry AVG
Production
with a gross margin of 22.8%, this company has a comparable cost of product (22.8%)
- Opd Laboratories Limited
22.8% - Industry AVG
Profitability
an operating margin of 1.8% make it less profitable than the average company (4.3%)
- Opd Laboratories Limited
4.3% - Industry AVG
Employees
with 66 employees, this is above the industry average (40)
66 - Opd Laboratories Limited
40 - Industry AVG
Pay Structure
on an average salary of £65k, the company has an equivalent pay structure (£65k)
- Opd Laboratories Limited
£65k - Industry AVG
Efficiency
resulting in sales per employee of £299.6k, this is less efficient (£576.2k)
- Opd Laboratories Limited
£576.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Opd Laboratories Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 2 days, this is quicker than average (32 days)
- Opd Laboratories Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Opd Laboratories Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (13 weeks)
4 weeks - Opd Laboratories Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 626%, this is a higher level of debt than the average (57.2%)
626% - Opd Laboratories Limited
57.2% - Industry AVG
opd laboratories limited Credit Report and Business Information
Opd Laboratories Limited Competitor Analysis
Perform a competitor analysis for opd laboratories limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
opd laboratories limited Ownership
OPD LABORATORIES LIMITED group structure
Opd Laboratories Limited has no subsidiary companies.
opd laboratories limited directors
Opd Laboratories Limited currently has 3 directors. The longest serving directors include Mr Manish Shah (Apr 1996) and Mr Rajesh Haria (Sep 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Manish Shah | 68 years | Apr 1996 | - | Director | |
| Mr Rajesh Haria | England | 59 years | Sep 2020 | - | Director |
| Mr Bhavin Shah | United Kingdom | 40 years | Sep 2020 | - | Director |
OPD LABORATORIES LIMITED financials
Opd Laboratories Limited's latest turnover from August 2022 is estimated at £19.8 million and the company has net assets of -£3 million. According to their latest financial statements, Opd Laboratories Limited has 66 employees and maintains cash reserves of £49.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 66 | 91 | 79 | 72 | 72 | 75 | 65 | |||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 44,579 | 63,922 | 5,114 | 6,818 | 5,628 | 7,504 | 10,005 | 13,340 | 17,787 | 19,767 | 26,639 | 35,244 | 25,723 | 33,097 |
| Intangible Assets | 97,976 | 91,270 | 136,004 | 183,534 | 248,176 | 293,251 | 306,406 | 154,144 | 86,493 | 51,529 | 109,657 | 173,846 | 239,611 | 244,508 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 66,160 | 66,160 | 66,160 | 0 | 0 | 0 | 1,262,408 | 1,262,408 |
| Total Fixed Assets | 142,555 | 155,192 | 141,118 | 190,352 | 253,804 | 300,755 | 382,571 | 233,644 | 170,440 | 71,296 | 136,296 | 209,090 | 1,527,742 | 1,540,013 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31,709 | 21,707 |
| Trade Debtors | 0 | 0 | 558 | 135,095 | 376,385 | 1,592,875 | 101,602 | 990,721 | 1,129,868 | 524,296 | 279,884 | 223,651 | 427,344 | 495,131 |
| Group Debtors | 66,160 | 66,160 | 66,160 | 66,160 | 66,160 | 66,160 | 66,160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 315,438 | 273,838 | 187,859 | 87,703 | 107,158 | 1,016,801 | 835,892 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 49,348 | 4 | 9 | 0 | 12,495 | 0 | 114,309 | 388,570 | 283,799 | 154,749 | 42,902 | 14,040 | 43,527 | 10,905 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 430,946 | 340,002 | 254,586 | 288,958 | 562,198 | 2,675,836 | 1,117,963 | 1,379,291 | 1,413,667 | 679,045 | 322,786 | 237,691 | 502,580 | 527,743 |
| total assets | 573,501 | 495,194 | 395,704 | 479,310 | 816,002 | 2,976,591 | 1,500,534 | 1,612,935 | 1,584,107 | 750,341 | 459,082 | 446,781 | 2,030,322 | 2,067,756 |
| Bank overdraft | 0 | 0 | 0 | 10 | 0 | 1,151,619 | 1,293,769 | 0 | 1,662,105 | 1,839,622 | 1,844,192 | 1,887,043 | 1,774,511 | 1,587,559 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 123,586 | 331,466 | 53,688 | 81,652 | 94,946 | 59,382 | 42,165 | 3,201,195 | 1,944,292 | 93,457 | 36,708 | 85,760 | 710,066 | 839,839 |
| Group/Directors Accounts | 300,000 | 3,263,140 | 2,801,181 | 2,370,117 | 845,901 | 1,367,516 | 1,800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 130,681 | 105,131 | 147,948 | 99,968 | 200,388 | 383,387 | 134,486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 554,267 | 3,699,737 | 3,002,817 | 2,551,747 | 1,141,235 | 2,961,904 | 3,270,420 | 3,201,195 | 3,606,397 | 1,933,079 | 1,880,900 | 1,972,803 | 2,484,577 | 2,427,398 |
| loans | 3,035,735 | 0 | 0 | 0 | 1,499,915 | 1,723,228 | 1,182,601 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,755,116 | 1,989,420 | 2,579,257 | 1,898,156 | 911,799 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 3,035,735 | 0 | 0 | 0 | 1,499,915 | 1,723,228 | 1,182,601 | 1,755,116 | 1,989,420 | 2,579,257 | 1,898,156 | 911,799 | 0 | 0 |
| total liabilities | 3,590,002 | 3,699,737 | 3,002,817 | 2,551,747 | 2,641,150 | 4,685,132 | 4,453,021 | 4,956,311 | 5,595,817 | 4,512,336 | 3,779,056 | 2,884,602 | 2,484,577 | 2,427,398 |
| net assets | -3,016,501 | -3,204,543 | -2,607,113 | -2,072,437 | -1,825,148 | -1,708,541 | -2,952,487 | -3,343,376 | -4,011,710 | -3,761,995 | -3,319,974 | -2,437,821 | -454,255 | -359,642 |
| total shareholders funds | -3,016,501 | -3,204,543 | -2,607,113 | -2,072,437 | -1,825,148 | -1,708,541 | -2,952,487 | -3,343,376 | -4,011,710 | -3,761,995 | -3,319,974 | -2,437,821 | -454,255 | -359,642 |
| Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 23,863 | 21,307 | 1,704 | 3,265 | 1,876 | 2,501 | 3,335 | 4,447 | 6,980 | 6,590 | 8,879 | 11,749 | 8,574 | 10,984 |
| Amortisation | 54,222 | 80,494 | 118,735 | 189,623 | 122,515 | 134,942 | 144,085 | 132,565 | 61,478 | 117,776 | 99,071 | 89,218 | 125,702 | 88,870 |
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -31,709 | 10,002 | 21,707 |
| Debtors | 41,600 | 85,421 | -34,381 | -260,745 | -2,126,133 | 1,606,022 | 12,933 | -139,147 | 671,732 | 244,412 | 56,233 | -1,466,101 | -67,787 | 1,757,539 |
| Creditors | -207,880 | 277,778 | -27,964 | -13,294 | 35,564 | 17,217 | -3,159,030 | 1,256,903 | 1,850,835 | 56,749 | -49,052 | -624,306 | -129,773 | 839,839 |
| Accruals and Deferred Income | 25,550 | -42,817 | 47,980 | -100,420 | -182,999 | 248,901 | 134,486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -2,963,140 | 461,959 | 431,064 | 1,524,216 | -521,615 | -432,484 | 1,800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 3,035,735 | 0 | 0 | -1,499,915 | -223,313 | 540,627 | 1,182,601 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -1,755,116 | -234,304 | -589,837 | 681,101 | 986,357 | 911,799 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 49,344 | -5 | 9 | -12,495 | 12,495 | -114,309 | -274,261 | 104,771 | 129,050 | 111,847 | 28,862 | -29,487 | 32,622 | 10,905 |
| overdraft | 0 | 0 | -10 | 10 | -1,151,619 | -142,150 | 1,293,769 | -1,662,105 | -177,517 | -4,570 | -42,851 | 112,532 | 186,952 | 1,587,559 |
| change in cash | 49,344 | -5 | 19 | -12,505 | 1,164,114 | 27,841 | -1,568,030 | 1,766,876 | 306,567 | 116,417 | 71,713 | -142,019 | -154,330 | -1,576,654 |
P&L
August 2022turnover
19.8m
-33%
operating profit
349.4k
0%
gross margin
22.8%
-2.19%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2022net assets
-3m
-0.06%
total assets
573.5k
+0.16%
cash
49.3k
+12336%
net assets
Total assets minus all liabilities
Similar Companies
opd laboratories limited company details
company number
03181478
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
April 1996
age
28
accounts
Small Company
ultimate parent company
previous names
N/A
incorporated
UK
address
fifth floor watson house, 54-60 baker street, london, W1U 7BU
last accounts submitted
August 2022
opd laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to opd laboratories limited. Currently there are 2 open charges and 4 have been satisfied in the past.
opd laboratories limited Companies House Filings - See Documents
| date | description | view/download |
|---|
